Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity.

Stewart DR, Dombroski BA, Urbanek M, Ankener W, Ewens KG, Wood JR, Legro RS, Strauss JF 3rd, Dunaif A, Spielman RS.

J Clin Endocrinol Metab. 2006 Oct;91(10):4112-7. Epub 2006 Jul 25.

PMID:
16868051
2.

Family-based analysis of candidate genes for polycystic ovary syndrome.

Ewens KG, Stewart DR, Ankener W, Urbanek M, McAllister JM, Chen C, Baig KM, Parker SC, Margulies EH, Legro RS, Dunaif A, Strauss JF 3rd, Spielman RS.

J Clin Endocrinol Metab. 2010 May;95(5):2306-15. doi: 10.1210/jc.2009-2703. Epub 2010 Mar 3.

3.

Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2.

Urbanek M, Woodroffe A, Ewens KG, Diamanti-Kandarakis E, Legro RS, Strauss JF 3rd, Dunaif A, Spielman RS.

J Clin Endocrinol Metab. 2005 Dec;90(12):6623-9. Epub 2005 Aug 9.

PMID:
16091490
4.

Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype.

Urbanek M, Sam S, Legro RS, Dunaif A.

J Clin Endocrinol Metab. 2007 Nov;92(11):4191-8. Epub 2007 Sep 4.

PMID:
17785364
5.

Microsatellite polymorphism in the fibrillin 3 gene and susceptibility to PCOS: a case-control study and meta-analysis.

Xie GB, Xu P, Che YN, Xia YJ, Cao YX, Wang WJ, Qiao D, Wu XK, Yi L, Gao Q, Wang Y.

Reprod Biomed Online. 2013 Feb;26(2):168-74. doi: 10.1016/j.rbmo.2012.10.014. Epub 2012 Oct 23.

PMID:
23265956
6.

The role of the polycystic ovary syndrome susceptibility locus D19S884 allele 8 in maternal glycemia and fetal size.

Ackerman CM, Lowe LP, Lee H, Chen F, Hughes E, Cholod P, Dyer AR, Hayes MG, Metzger BE, Lowe WL, Urbanek M; HAPO Study Cooperative Research Group.

J Clin Endocrinol Metab. 2010 Jul;95(7):3242-50. doi: 10.1210/jc.2009-2718. Epub 2010 May 5.

7.

Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries.

Prodoehl MJ, Hatzirodos N, Irving-Rodgers HF, Zhao ZZ, Painter JN, Hickey TE, Gibson MA, Rainey WE, Carr BR, Mason HD, Norman RJ, Montgomery GW, Rodgers RJ.

Mol Hum Reprod. 2009 Dec;15(12):829-41. doi: 10.1093/molehr/gap072. Epub 2009 Aug 19.

8.

Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin.

Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, Norman RJ, Strauss JF 3rd, Spielman RS, Dunaif A.

Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8573-8.

9.

Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome.

Waterworth DM, Bennett ST, Gharani N, McCarthy MI, Hague S, Batty S, Conway GS, White D, Todd JA, Franks S, Williamson R.

Lancet. 1997 Apr 5;349(9057):986-90.

PMID:
9100625
10.

Evidence for association of polycystic ovary syndrome in caucasian women with a marker at the insulin receptor gene locus.

Tucci S, Futterweit W, Concepcion ES, Greenberg DA, Villanueva R, Davies TF, Tomer Y.

J Clin Endocrinol Metab. 2001 Jan;86(1):446-9.

PMID:
11232039
11.

[Association between single nucleotide polymorphism of rs2252673 of INSR gene and polycystic ovarian syndrome].

Du J, Wang Z, Zhang J, Jia L, Zhang F, Shi Y, Chen Z.

Zhonghua Fu Chan Ke Za Zhi. 2014 Dec;49(12):919-24. Chinese.

PMID:
25608993
12.

Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry.

Mutharasan P, Galdones E, Peñalver Bernabé B, Garcia OA, Jafari N, Shea LD, Woodruff TK, Legro RS, Dunaif A, Urbanek M.

J Clin Endocrinol Metab. 2013 Jan;98(1):E185-90. doi: 10.1210/jc.2012-2471. Epub 2012 Nov 1.

13.

The genetics of the polycystic ovary syndrome.

Urbanek M.

Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):103-11. Review.

PMID:
17237837
14.

Family-based analysis of susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3.

Zhao H, Xu X, Xing X, Wang J, He L, Shi Y, Shi Y, Zhao Y, Chen ZJ.

Hum Reprod. 2012 Jan;27(1):294-8. doi: 10.1093/humrep/der379. Epub 2011 Nov 10.

PMID:
22081247
15.

Family association study between tumour necrosis factor a gene polymorphisms and polycystic ovary syndrome in Han Chinese.

Diao X, Han T, Zhang Y, Ma J, Shi Y, Chen ZJ.

Reprod Biomed Online. 2014 Nov;29(5):581-7. doi: 10.1016/j.rbmo.2014.07.005. Epub 2014 Jul 21.

PMID:
25246119
16.

Parent-of-origin effects on glucose homeostasis in polycystic ovary syndrome.

Kobaly K, Vellanki P, Sisk RK, Armstrong L, Lee JY, Lee J, Hayes MG, Urbanek M, Legro RS, Dunaif A.

J Clin Endocrinol Metab. 2014 Aug;99(8):2961-6. doi: 10.1210/jc.2013-4338. Epub 2014 May 30.

17.

Family-based analysis of eight susceptibility loci in polycystic ovary syndrome.

Zhao S, Tian Y, Gao X, Zhang X, Liu H, You L, Cao Y, Su S, Chan WY, Sun Y, Zhao H, Chen ZJ.

Sci Rep. 2015 Jul 29;5:12619. doi: 10.1038/srep12619.

18.

Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2.

Biyasheva A, Legro RS, Dunaif A, Urbanek M.

J Clin Endocrinol Metab. 2009 Jul;94(7):2617-25. doi: 10.1210/jc.2008-1664. Epub 2009 Apr 7.

19.

Epigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndrome.

Hickey TE, Legro RS, Norman RJ.

J Clin Endocrinol Metab. 2006 Jul;91(7):2789-91. Epub 2006 Apr 24.

PMID:
16636126
20.

Family-based association study of the MCF2L2 gene and polycystic ovary syndrome.

Zheng Q, Shi Y, Yang Z, Xu X, Wang L, Xue F, Gu HF, Chen ZJ.

Gynecol Obstet Invest. 2009;68(3):171-3. doi: 10.1159/000231520. Epub 2009 Jul 31.

PMID:
19648752

Supplemental Content

Support Center